Correction: A human Myogenin promoter modified to be highly active in alveolar rhabdomyosarcoma drives an effective suicide gene therapy | Zendy

AI Assistant Blog Pricing

Correction: A human Myogenin promoter modified to be highly active in alveolar rhabdomyosarcoma drives an effective suicide gene therapy

Details

The content you want is available to Zendy users.Already have an account? Click here. to sign in.